VERSAVO 400MG INJECTION contains Bevacizumab which belongs to the group of medicines called Antineoplastic agents. It is used in adult patients with Fluoropyrimidine (chemotherapy medicine) to treat metastatic cancer in large bowel (colon or rectum). It is also used with Paclitaxel/ Capecitabine (chemotherapy medicine) to treat metastatic breast cancer in adult patients.
VERSAVO 400MG INJECTION is used with chemotherapy regimen containing Platinum to treat advanced non-small cell lung cancer without epidermal growth factor receptor (mutated protein responsible to cause cancer in a cell) and with Erlotinib (chemotherapy medicine) to treat metastatic non-small cell lung cancer with epidermal growth factor receptor (in cancer cells) in adult patients. The medicine is indicated for use to treat metastatic kidney cancer along with interferon (chemotherapy medicine) which is also indicated for use with Carboplatin, Gemcitabine, and/or with Carboplatin and Paclitaxel (chemotherapy medicine) to treat recurrent advanced epithelial ovarian, fallopian tube/primary peritoneal cancer in adult patients. The medicine is also used to treat persistent, recurrent or metastatic cervical cancer with/without Paclitaxel and Cisplatin/ Paclitaxel and Topotecan in adult patients.
VERSAVO 400MG INJECTION is not recommended for use if in patients allergic to Bevacizumab, Chinese hamster ovary (CHO) cell products, and/or other recombinant human/humanised antibodies. It is also not recommended for use in patients who had recently undergone major operation/surgery.
Before receiving VERSAVO 400MG INJECTION, inform your doctor if you are scheduled for an invasive dental treatment/surgery, and/or suffer from conditions such as inflammation inside the abdomen, uncontrolled high blood pressure, dental problems, kidney problems, and liver problems (such as hepatic injury).
VERSAVO 400MG INJECTION is not recommended for use in pregnant women and in women planning for pregnancy since it may cause harm to the unborn baby. It is also not recommended for use in breast-feeding women since it may interfere with the growth and development of the baby.
VERSAVO 400MG INJECTION is not recommended for use in children and adolescents (aged below 18 years) since safety and efficacy of the medicine is not established in this age group. It is advised to be used with caution in elderly patients (aged 65 years and above) after consulting the doctor.
The most common side effects of receiving VERSAVO 400MG INJECTION are constipation, loss of appetite, fever, eye problems (such as increase in production of tears), changes in speech/sense of taste, runny nose, and/or loss of body weight. Consult your doctor if any of these symptoms worsens.
Treats:
VERSAVO 400MG INJECTION works by reducing microvascular growth of tumour blood vessels which leads to reduced blood flow to the tumour cells resulting in its death thus treating the disease and preventing its spread to other parts of the body in affected individuals.
VERSAVO 400MG INJECTION will be given to you only by a doctor or a nurse into a vein as an intravenous infusion. Your doctor will determine the correct dose and duration for you based upon your age, body weight and disease condition.
Stop receiving VERSAVO 400MG INJECTION and contact your doctor immediately if you experience any of the following side effects:
Try to eat high-fiber foods such as vegetables, cereals, fresh fruit, and drink plenty of water. Involve in regular exercise (going for a daily walk or run) and if this does not help, consult and inform your doctor for receiving alternate treatments for constipation.
Try moisturizing your skin with an ointment, cream, or lotion 2 or 3 times a day, or as often as needed. Moisturizers help to keep the area moisture, so they work best on damp skin. After you bathe, pat your skin dry then apply your moisturizer. Try to avoid using skin care products and soaps that contain alcohol, fragrances, dyes, or other chemicals.
VERSAVO 400MG INJECTION is not recommended for use in pregnant women and in women planning for pregnancy since it may cause harm to the unborn baby. Women of child bearing potential should use effective contraceptives during and after stopping treatment with medicine for next 6 months to prevent accidental pregnancy. If pregnancy occurs during treatment with VERSAVO 400MG INJECTION, then it should be informed to your doctor immediately. Consult your doctor before receiving the medicine.
VERSAVO 400MG INJECTION is not recommended for use in breast-feeding women during and for next 6 months of therapy after stopping the medicine since it may interfere with the growth and development of your baby. Consult your doctor before receiving the medicine.
Do not drive or operate machines if you experience sleepiness/fainting after receiving the medicine.
VERSAVO 400MG INJECTION should be used with caution in patients with kidney problems. Consult your doctor before receiving the medicine.
VERSAVO 400MG INJECTION should be used with caution in patients with liver problems such as hepatic injury. Consult your doctor before receiving the medicine.
Do not receive VERSAVO 400MG INJECTION if you are allergic to Bevacizumab, Chinese hamster ovary (CHO) cell products, other recombinant human/humanised antibodies, and/or any other ingredients of this medicine.
VERSAVO 400MG INJECTION should be used with caution in patients with a history of risk of bleeding in lungs. Consult your doctor before receiving the medicine.
VERSAVO 400MG INJECTION should be used with caution in patients with heart problems such as heart attack and stroke. Consult your doctor before receiving the medicine.
VERSAVO 400MG INJECTION is not recommended for use if you:
Before receiving VERSAVO 400MG INJECTION, inform your doctor if you:
Use in Paediatrics:
VERSAVO 400MG INJECTION is not recommended for use in children and adolescents (aged below 18 years) since safety and efficacy of the use of medicine is not established in in this age group. Consult your doctor before receiving the medicine.
Use in Geriatrics:
VERSAVO 400MG INJECTION should be used with caution in elderly patients (aged 65 years and above). Consult your doctor before receiving the medicine.
A. Drug-Drug interactions:
Before receiving VERSAVO 400MG INJECTION, inform your doctor if you are receiving any of the following medicine:
Overdosage:
VERSAVO 400MG INJECTION will be administered to you only by a doctor or a nurse in a hospital, and so it is unlikely to receive an overdose. However, consult your doctor or nurse if you experience any unusual symptoms.
Drug | : | Bevacizumab |
Pharmacological Category | : | Antineoplastics |
Therapeutic Indication | : | Metastatic cancer in large bowel (colon/rectum), breast, kidney, Advanced non-small cell lung cancer (with/without epidermal growth factor receptor), Recurrent advanced epithelial ovarian, fallopian tube/primary peritoneal cancer, Persistent/recurrent/metastatic cervical cancer |
Dosage Forms | : | Injection |
Q. What is VERSAVO 400MG INJECTION used for?
A. VERSAVO 400MG INJECTION is used in adult patients to treat metastatic cancer in large bowel (colon/rectum), breast, kidney, and lungs. It is also used to treat recurrent advanced epithelial ovarian, fallopian tube/primary peritoneal cancer, and/or persistent/recurrent/metastatic cervical cancer in affected individuals.
Q. How VERSAVO 400MG INJECTION works?
A. VERSAVO 400MG INJECTION works by reducing microvascular growth of tumour blood vessels which leads to reduced blood flow to the tumour cells resulting in its death thus treating the disease and preventing its spread to other parts of the body in affected individuals.
Q. What are the common side effects of receiving VERSAVO 400MG INJECTION?
A. The most common side effects of receiving VERSAVO 400MG INJECTION are constipation, loss of appetite, fever, eye problems (such as increase in production of tears), changes in speech/sense of taste, runny nose, and/or loss of body weight. Consult your doctor if any of these symptoms worsens.
Q. How VERSAVO 400MG INJECTION is administered?
A. VERSAVO 400MG INJECTION will be given to you only by a doctor or a nurse into a vein as an intravenous infusion. Your doctor will determine the correct dose and duration for you based upon your age, body weight and disease condition.
Q. Can VERSAVO 400MG INJECTION be administered in pregnant and breastfeeding women?
A. No, VERSAVO 400MG INJECTION is not recommended for use in pregnant women and in women planning for pregnancy since it may cause harm to the unborn baby. It is also not recommended for use in breast-feeding women since it may interfere with the growth and development of the baby. Consult your doctor before receiving the medicine.
1. KD Tripathi MD. Anticancer Drugs. Essentials of Medical Pharmacology 8th edition. 2019. Page- 930.
2. Filis Kazazi-Hyseni, Jos H. Beijnen, Jan H. M. Schellen. Bevacizumab. NIH National Library of Medicine. National Center for Biotechnology Information. PMC PubMed Central. August 2010. [Accessed on 30th January 2023] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228024/
3. Pfizer Ireland Pharmaceuticals. Electronic Medicines Compendium (EMC). [Revised in January 2023] [Accessed on 30th January 2023] https://www.medicines.org.uk/emc/files/pil.13267.pdf
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.